Daniel Ek: Life After Spotify, Broken Healthcare Incentives, Catching Disease Early & AI's Potential

Daniel Ek arrives on the show introduced by numbers rather than narrative: Spotify, which he co-founded twenty years earlier and ran for those two decades, now carries well over 700,000,000 active users and more than 300,000,000 premium subscribers. On January 1 he moved from chief executive to executive chairman. The framing matters for everything that follows, because Ek's second company is being presented not as a side project by a wealthy technologist but as a deliberate re-run of an operating playbook he has already executed once at scale.

Ek's own opening line about the Spotify years is a joke that doubles as a disclaimer: he had hair when he started and was bald by the end, so the audience can see it was not an easy journey. He dates the beginning precisely — Spotify in 2006, when he was 23 — and then locates the company in a technological moment that is now genuinely hard to reconstruct: pre-iPhone, pre-YouTube, with Facebook existing but restricted to colleges.

The second company is Neko Health. Ek says it was started eight years ago, in 2018, and that the product did not reach paying customers in Sweden until 2023 — five years of development before the first market. Once Sweden worked, the company went to the UK, and only then to the United States. He describes this explicitly as the Spotify sequence repeated: build, prove in a small home market, expand to an adjacent one, and enter the US last.

When Friedberg suggests that the affliction of great entrepreneurs is simply that they cannot stop, Ek offers a less flattering explanation — that he may just have a high pain tolerance — and does not resolve which is true. It is a small exchange, but it sets the tone for the interview: Ek is consistently more willing to describe mechanics than to accept a flattering motive.

The music industry Ek walked into was collapsing. Piracy was rampant — Napster, Kazaa, and a wave of similar services — and the RIAA was responding by suing individual American consumers for illegal downloading. Sitting in Sweden, Ek's read was that the situation was irreversible: there was no way to put the genie back in the bottle.

The origin conversation was with his co-founder Martin, who asked what Ek would do if he could do anything at all. Ek named music, then immediately argued himself out of it: the record deals, the licensing, the copyright machinery all made it seem like a stupid idea. Martin kept asking what-if questions until Ek ran out of reasons to refuse, and the description he landed on is the product thesis in one sentence — it would feel like you had all the world's music at your fingertips.

The reason Spotify could be built from Sweden rather than from a major market is the most counterintuitive part of the story. Sweden was one of the worst music markets in the world, and it was worst precisely because it was early: super-fast broadband arrived there in the early 2000s, so users could download essentially anything they wanted, and iTunes was not even available in the market. There were, in Ek's phrase, literally no legal options. The industry had lost something on the order of 80% of its revenues.

That combination — a population already trained to expect unlimited access, and an industry desperate enough to negotiate — is what made a licensing deal possible at all. It is a structural argument, not a heroic one, and Ek tells it that way.

Ek and his partner put in all the money they had made from prior startups and used it as a negotiating instrument rather than as capital. The offer to the labels was a downside cap: if the service was as bad as the labels believed, they would shut it down after a year, and the labels would still have made their bonus and their budget for that year. If it worked, the labels won as well. Ek's summary of the pitch is that they win no matter what.

The labels found the structure interesting but did not move quickly. Negotiation took years. Spotify launched in late 2008 and became a hit immediately, then repeated the pattern in the UK, and entered the US in 2011 — which Ek notes was fifteen years before this conversation.

Friedberg's reaction is the right one: five years in the laboratory before reaching the US market is a long time to absorb pain and suffering. That observation is what makes the Neko timeline legible rather than eccentric. Ek is not claiming healthcare is easy; he is claiming he has already spent five years being told no by gatekeepers before, and that the waiting is a known cost rather than a surprise.

Ek's interest in healthcare is older than most listeners would assume. His team recently showed him a 2012 or 2013 interview, recorded shortly after the US Spotify launch, in which he was already discussing it. His stated disposition is that most things in the world are improving — the technology curve is up and to the right — and that his attention goes to the exceptions that are not.